Edwards Lifesciences Corporatio

$75.74

Name : Edwards Lifesciences Corporatio

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $44,466,954,240.00

EPSttm : 2.39

Edwards Lifesciences Corporatio

$75.74

1.28%

$0.98

Float Short %

1.26

Margin Of Safety %

Put/Call OI Ratio

1.1

EPS Next Q Diff

-0.06

EPS Last/This Y

-4.47

EPS This/Next Y

0.28

Price

75.75

Target Price

88.07

Analyst Recom

2.11

Performance Q

-3.88

Relative Volume

1.25

Beta

1.03

Ticker: EW

23 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	EW	80.26	1.08	1.29	70544
2025-09-09	EW	79.82	1.08	0.75	70604
2025-09-10	EW	78.27	1.08	0.67	70757
2025-09-11	EW	77.97	1.08	2.52	71119
2025-09-12	EW	77.56	1.08	3.71	71232
2025-09-15	EW	76.05	1.11	1.60	73201
2025-09-16	EW	75.09	1.11	0.04	73277
2025-09-17	EW	75.2	0.95451293815832	0.56859205776173	79234
2025-09-18	EW	74.54	0.93	0.37	79986
2025-09-19	EW	74.41	0.80	0.20	85569
2025-09-22	EW	73.72	0.86	0.55	69186
2025-09-23	EW	74.56	0.84	0.39	71059
2025-09-24	EW	74.67	0.84	7.11	71933
2025-09-25	EW	75.28	0.86	0.85	72989
2025-09-26	EW	76.27	0.86	0.39	73241
2025-09-29	EW	77.19	1.14	0.16	84534
2025-09-30	EW	77.78	1.10	0.26	86096
2025-10-01	EW	76.32	1.09	0.80	86259
2025-10-02	EW	76.67	1.10	0.71	86498
2025-10-03	EW	77.07	1.10	0.14	86947
2025-10-06	EW	76.57	1.09	1.51	87571
2025-10-07	EW	76.71	1.10	0.49	89691
2025-10-08	EW	75.74	1.10	0.19	89660
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	EW	80.21	-12.3	73.7	2.50
2025-09-09	EW	79.84	-12.3	82.1	2.50
2025-09-10	EW	78.29	-12.3	54.8	2.50
2025-09-11	EW	78.01	-12.3	84.3	2.50
2025-09-12	EW	77.58	-12.3	80.4	2.50
2025-09-15	EW	76.06	-12.3	53.6	2.50
2025-09-16	EW	75.09	-12.3	66.7	2.50
2025-09-17	EW	75.19	-12.2	93.4	2.50
2025-09-18	EW	74.54	-12.2	74.0	2.50
2025-09-19	EW	74.40	-12.2	87.0	2.50
2025-09-22	EW	73.75	-12.2	73.9	2.50
2025-09-23	EW	74.57	-12.2	112.0	2.51
2025-09-24	EW	74.64	-12.2	92.6	2.51
2025-09-25	EW	75.27	-11.9	106.4	2.51
2025-09-26	EW	76.25	-11.9	115.7	2.51
2025-09-29	EW	77.18	-11.9	114.1	2.51
2025-09-30	EW	77.77	-11.9	105.2	2.51
2025-10-01	EW	76.30	-11.9	54.8	2.51
2025-10-02	EW	76.65	-11.9	99.5	2.51
2025-10-03	EW	77.07	-11.9	101.2	2.51
2025-10-06	EW	76.56	-11.9	88.6	2.51
2025-10-07	EW	76.69	-11.9	94.1	2.51
2025-10-08	EW	75.75	-11.7	84.3	2.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	EW	-0.83	-0.87	1.42
2025-09-09	EW	-0.83	-0.87	1.42
2025-09-10	EW	-0.83	-0.87	1.42
2025-09-11	EW	-0.78	-0.87	1.80
2025-09-12	EW	-0.78	-0.87	1.80
2025-09-15	EW	-0.70	-0.87	1.80
2025-09-16	EW	-0.70	-0.87	1.80
2025-09-17	EW	-0.70	-0.87	1.80
2025-09-18	EW	-0.70	-0.87	1.80
2025-09-19	EW	-0.70	-0.87	1.80
2025-09-22	EW	-0.70	-0.88	1.80
2025-09-23	EW	-0.70	-0.88	1.80
2025-09-24	EW	-0.70	-0.88	1.80
2025-09-25	EW	-0.70	-0.88	1.26
2025-09-26	EW	-0.70	-0.88	1.26
2025-09-29	EW	-0.61	-0.88	1.26
2025-09-30	EW	-0.61	-0.88	1.26
2025-10-01	EW	-0.61	-0.88	1.26
2025-10-02	EW	-0.61	-0.88	1.26
2025-10-03	EW	-0.61	-0.88	1.26
2025-10-06	EW	-0.61	-0.81	1.26
2025-10-07	EW	-0.61	-0.81	1.26
2025-10-08	EW	-0.61	-0.81	1.26
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

0.67

Avg. EPS Est. Current Quarter

0.59

Avg. EPS Est. Next Quarter

0.61

Insider Transactions

-0.61

Institutional Transactions

-0.81

Beta

1.03

Average Sales Estimate Current Quarter

1494

Average Sales Estimate Next Quarter

1542

Fair Value

75.84

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

42.5

Max Drawdown 5-Year %

-54.3

Target Price

88.07

P/E

51.71

Forward P/E

27.08

PEG

5.71

P/S

7.82

P/B

4.22

P/Free Cash Flow

75.64

EPS

1.46

Average EPS Est. Cur. Y

2.51

EPS Next Y. (Est.)

2.79

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.11

Relative Volume

1.25

Return on Equity vs Sector %

14.1

Return on Equity vs Industry %

20.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

84.3

Edwards Lifesciences Corporatio

Sector: Healthcare

Industry: Medical Devices

Employees: 15800

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

stock quote shares EW – Edwards Lifesciences Corporation Stock Price stock today

news today EW – Edwards Lifesciences Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch EW – Edwards Lifesciences Corporation yahoo finance google finance

stock history EW – Edwards Lifesciences Corporation invest stock market

stock prices EW premarket after hours

ticker EW fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EW

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y